High-Cost Generic Drugs—Implications for Patients and Policymakers (Reply)

Responding to FDA officials, the authors acknowledge that faster generic drug application review is helpful but argue that additional interventions are needed to address the multiple causes of high generic drug prices, including fluctuating demand and anticompetitive business practices.